Andy Jenks

[Paul Huang Lab @HuangLabICR]

The lab has a new review to announce! Congratulations to @SimonVyse for his review into Exon 20 EGFR mutations in non-small cell lung cancer published today in Signal Transduction & Targeted Therapy @nresearchnews @nature https://t.co/naX9s38yCH #NSCLC #Exon20

[Paul Huang Lab @HuangLabICR]

Hi, I’m @AndyJenks4. I study how sub-clonal interactions and tumour heterogeneity are driving acquired resistance to clinically available EGFR inhibitors, in order to identify novel treatment strategies for lung cancer @ICR_London #GameOfClones